Magle Chemoswed Feed

2026-02-18 18:00:00 Magle Group Issues Profit Warning Ahead of Q4 and Full-Year 2025 Results

2026-01-29 11:18:00 Magle Group Announces Strategic Refocus to Strengthen Profitability and Operational Discipline 10,50 SEK | -4,55% | 0,30 MSEK

2026-01-21 13:52:00 Magle Group Announces Planned Transition in Chief Operating Officer Role 14,60 SEK | -11,52% | 0,12 MSEK

2026-01-02 13:03:00 Magle Group today announces a change in executive leadership 17,10 SEK | -2,84% | 0,03 MSEK

2025-12-16 13:33:00 Magle Chemoswed Holding AB announces change of Certified Adviser to Redeye 15,00 SEK | -5,06% | 0,20 MSEK

2025-12-01 15:00:00 Magle Group Enters Strategic Distribution Agreement with Rifa Pharma for SmartPAN® and SmartGEL® in India. 17,70 SEK | -0,56% | 0,08 MSEK

2025-11-27 08:30:00 Magle Chemoswed Holding Announces Chairman Transition 17,60 SEK | -0,56% | 0,04 MSEK

2025-11-17 14:53:00 Magle Group Completes European Medical Device Filing for the Use of EmboCept® S in Genicular Artery Embolisation 19,10 SEK | +0,53% | 0,10 MSEK

2025-11-14 08:30:00 Magle Chemoswed Holding Reports Financial Results For Third Quarter 2025 19,00 SEK | -8,65% | 0,15 MSEK

2025-10-31 08:30:00 Magle Group Announces Revised Publication Date for Q3 2025 Due to Ongoing Consolidation Processes 19,00 SEK | -6,86% | 0,08 MSEK

2025-10-23 15:25:00 Magle Group sponsors inaugural VENTI Conference in Tokyo, Japan — supporting innovation in vascular embolotherapy and pain interventions 19,50 SEK | +2,63% | 0,00 MSEK

2025-10-22 08:56:00 Magle Biopolymers receives 2026 order showing a material increase in demand for one of its proprietary dextran derivatives 19,00 SEK | -7,77% | 0,42 MSEK

2025-10-20 10:40:00 Magle Group announces positive clinical evidence review of EmboCept® S for Genicular Artery Embolisation (GAE); regulatory filing in Europe now in preparation 20,60 SEK | +4,04% | 0,05 MSEK

2025-10-02 07:45:00 Magle Group Secures Registration of SmartPAN® in Singapore, Enabling Launch in Pancreatic Surgery 19,20 SEK | 0,00% | 0,01 MSEK

2025-08-01 07:30:00 Magle Chemoswed Holding Reports Financial Results For Second Quarter 2025 20,60 SEK | -2,83% | 0,21 MSEK

2025-07-29 09:00:00 Magle Group’s financial results for the second quarter anticipated to fall short of market expectations. 23,20 SEK | -12,12% | 0,30 MSEK

2025-06-24 17:20:00 Magle Group successfully places senior secured bonds of SEK 350 million 26,80 SEK | -0,74% | 0,00 MSEK

2025-06-13 07:30:00 Magle Group contemplates issuance of senior secured bonds 26,80 SEK | +2,29% | 0,02 MSEK

2025-06-05 17:54:00 The acquisition of all shares in Saving Chlora AB has been completed

2025-05-26 15:00:00 Bulletin from Annual General Meeting in Magle Chemoswed Holding AB (publ) held on the 26th of May 2025 26,40 SEK | +1,54% | 0,03 MSEK

2025-05-26 15:00:00 Kommuniké från årsstämma i Magle Chemoswed Holding AB (publ) den 26 maj 5 26,40 SEK | +1,54% | 0,03 MSEK

2025-05-22 09:56:00 Magle Chemoswed Holding Reports Financial Results For First Quarter 2025 25,40 SEK | -3,05% | 0,20 MSEK

2025-05-05 17:30:00 Magle Chemoswed Holding AB (publ) Releases Annual Report for 2024. 25,60 SEK | -1,54% | 0,05 MSEK

2025-04-27 18:30:00 Malmö, Sweden – Magle Group announces a revised publication date for its 2024 Annual Report, and its Q1 2025 Interim Report. 29,00 SEK | +2,11% | 0,00 MSEK

2025-04-25 16:30:00 Correction: Magle Chemoswed Holding Reports Financial Results For Fourth Quarter 2024 28,40 SEK | -1,39% | 0,01 MSEK

2025-04-25 09:00:00 Magle PharmaCept Partners with Pancreatic Cancer Europe PCE to Advance Innovation in Pancreatic Cancer Care 28,40 SEK | -1,39% | 0,01 MSEK

2025-04-24 11:15:00 Magle Group Announces Acquisition of Saving Chlora AB 28,80 SEK | +0,70% | 0,06 MSEK

2025-04-24 09:00:00 Kallelse till årsstämma i Magle Chemoswed Holding AB (publ) 28,80 SEK | +0,70% | 0,06 MSEK

2025-04-24 09:00:00 Notice of Annual General Meeting in Magle Chemoswed Holding AB (publ) 28,80 SEK | +0,70% | 0,06 MSEK

2025-03-27 08:30:00 Magle Chemoswed Holding Reports Financial Results For Fourth Quarter 2024 31,00 SEK | -5,49% | 0,08 MSEK

2025-03-19 08:15:00 Magle Group initiates Randomized Controlled Multicenter Trial with leading European university hospitals to explore SmartPAN® efficacy 31,00 SEK | 0,00% | 0,00 MSEK

2025-02-26 18:00:00 Ingela Fritzson resigns from the Board of Directors of Magle Group 31,00 SEK | -4,32% | 0,16 MSEK

2025-02-17 09:00:00 Magle Group is pleased to announce Magle PharmaCept’s participation in the DPC, German Pancreatic Club congress, set to take place February 27-March 1, 2025, in Heidelberg, Germany. 34,60 SEK | +1,76% | 0,08 MSEK

2025-02-14 08:05:00 Magle Group Announces Revised Publication Date for Q4 2024 and Full-Year 2024 Reports Due to Ongoing Consolidation Process 34,00 SEK | 0,00% | 0,02 MSEK

2025-01-09 21:45:00 Magle Group offentliggör tilldelning i den riktade emissionen 37,40 SEK | 0,00% | 0,01 MSEK

2025-01-09 21:45:00 Magle Group announces allocation in the directed share issue 37,40 SEK | 0,00% | 0,01 MSEK

2024-12-30 12:30:00 Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB 34,80 SEK | +4,82% | 0,19 MSEK

2024-12-30 12:30:00 Kommuniké från extra bolagsstämma i Magle Chemoswed Holding AB 34,80 SEK | +4,82% | 0,19 MSEK

2024-12-20 15:30:00 Magle Group raises approximately SEK 36.8 million in the rights issue 34,00 SEK | +2,41% | 0,18 MSEK

2024-12-20 15:30:00 Magle Group tillförs cirka 36,8 MSEK i företrädesemissionen 34,00 SEK | +2,41% | 0,18 MSEK

2024-12-16 15:30:00 Magle Group offentliggör tilläggsprospekt 31,80 SEK | -3,64% | 0,08 MSEK

2024-12-16 15:30:00 Magle Group publishes supplementary prospectus 31,80 SEK | -3,64% | 0,08 MSEK

2024-12-16 10:40:00 Magle Group Approves Multi-Centre Clinical Trial in Genicular Artery Embolisation for Osteoarthritis Pain Relief 31,80 SEK | -3,64% | 0,08 MSEK

2024-12-12 22:45:00 Notice to the extraordinary general meeting in Magle Chemoswed Holding AB (publ) 33,00 SEK | +0,61% | 0,07 MSEK

2024-12-12 22:45:00 Kallelse till extra bolagsstämma i Magle Chemoswed Holding AB (publ) 33,00 SEK | +0,61% | 0,07 MSEK

2024-12-12 22:00:00 Magle Group resolves on a conditional directed share issue of up to approximately SEK 26.6 million 33,00 SEK | +0,61% | 0,07 MSEK

2024-12-12 22:00:00 Magle Group beslutar om en villkorad riktad nyemission om upp till cirka 26,6 MSEK 33,00 SEK | +0,61% | 0,07 MSEK

2024-12-10 18:00:00 Magle Group publishes supplementary prospectus 33,20 SEK | +4,40% | 0,10 MSEK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Magle Chemoswed

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden